Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma
- Resource Type
- Article
- Source
- In
Journal of Thoracic Oncology March 2017 12(3):477-490 - Subject
- Language
- ISSN
- 1556-0864